(Q31912488)

5 July 2017

Targets of a protease inhibitor, KNI-272, in HIV-1-infected cells (English)

1 reference

5 July 2017

Goto T

1

1 reference

5 July 2017

Nakano T

2

1 reference

5 July 2017

Kohno T

3

1 reference

5 July 2017

Morimatsu S

4

1 reference

5 July 2017

Morita C

5

1 reference

5 July 2017

Hong W

6

1 reference

5 July 2017

Kiso Y

7

1 reference

5 July 2017

Nakai M

8

1 reference

5 July 2017

Sano K

9

1 reference

5 July 2017

1 March 2001

1 reference

Journal of Medical Virology

5 July 2017

1 reference

5 July 2017

63

1 reference

5 July 2017

3

1 reference

5 July 2017

203-209

1 reference

An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection

5 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

HIV-1 proteinase is required for synthesis of pro-viral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

The life-cycle of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Kynostatin (KNI)-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Rational design of peptide-based HIV proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

HIV-1 protease does not play a critical role in the early stages of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

Nucleotide sequence of the AIDS virus, LAV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

An Improved Non-Radioisotopic Reverse Transcriptase Assay and Its Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

A unique monoclonal antibody that recognizes mature p17 of HIV-1 but not its precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1096-9071%28200103%2963%3A3%3C203%3A%3AAID-JMV1001%3E3.0.CO%3B2-F

10.1002/1096-9071(200103)63:3<203::AID-JMV1001>3.0.CO;2-F

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference